Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Reprod Toxicol. 2013 Sep 30;44:41–49. doi: 10.1016/j.reprotox.2013.09.005

Figure 1. Model depicting the experimental dosing protocol.

Figure 1

In short, the continous dose group was exposed via gastric gavage to either saline or 10mg/kg of As(III) starting at post natal day (PND) day 12 until vaginal opening. Stop dose group was dosed until PND 30, at which time tissue and serum was collected for analysis.